510(k) K241220
K241220 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Operations for the device "Tina-quant Lipoprotein(a) Gen.2 Molarity". The FDA issued a decision of Substantially Equivalent on January 24, 2025. The device falls under product code DFC (Lipoprotein, Low-Density, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5600. Roche Diagnostics Operations has at least 6 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 24, 2025
- Date Received
- May 1, 2024
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Lipoprotein, Low-Density, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5600
- Review Panel
- IM
- Submission Type